New roles for Gsk-3β and Wnts during skull vault osteogenesis

被引：0
|
作者：
Rogers, Heather L. Szabo [1 ]
Smithers, Lucy E. [1 ]
Liu, Karen J. [1 ]
机构：
[1] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England
来源：
GENETICS RESEARCH | 2010年 / 92卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [21] A NEW CLASS OF MOLECULAR TARGETED RADIOPROTECTORS: GSK-3β INHIBITORS
    Thotala, Dinesh K.
    Geng, Ling
    Dickey, Amy K.
    Hallahan, Dennis E.
    Yazlovitskaya, Eugenia M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (02): : 557 - 565
  • [22] Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
    McCubrey, J. A.
    Steelman, L. S.
    Bertrand, F. E.
    Davis, N. M.
    Abrams, S. L.
    Montalto, G.
    D'Assoro, A. B.
    Libra, M.
    Nicoletti, F.
    Maestro, R.
    Basecke, J.
    Cocco, L.
    Cervello, M.
    Martelli, A. M.
    LEUKEMIA, 2014, 28 (01) : 15 - 33
  • [23] The Roles of GSK-3β in Regulation of Retinoid Signaling and Sorafenib Treatment Response in Hepatocellular Carcinoma
    Zhang, Shuaishuai
    Gao, Weiwei
    Tang, Juan
    Zhang, Huaifang
    Zhou, Yuqi
    Liu, Jie
    Chen, Kun
    Liu, Fangzhou
    Li, Wengang
    To, Sally K. Y.
    Wong, Alice Sze Tsai
    Zhang, Xiao-Kun
    Zhou, Hu
    Zeng, Jin-Zhang
    THERANOSTICS, 2020, 10 (03): : 1230 - 1244
  • [24] Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention
    J A McCubrey
    L S Steelman
    F E Bertrand
    N M Davis
    S L Abrams
    G Montalto
    A B D'Assoro
    M Libra
    F Nicoletti
    R Maestro
    J Basecke
    L Cocco
    M Cervello
    A M Martelli
    Leukemia, 2014, 28 : 15 - 33
  • [25] Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
    Freyberg, Zachary
    Ferrando, Stephen J.
    Javitch, Jonathan A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2010, 167 (04): : 388 - 396
  • [26] PTEN regulation by the Akt/GSK-3β axis during RANKL signaling
    Jang, Hyun Duk
    Noh, Ji Yeon
    Shin, Ji Hye
    Lin, Jing Jing
    Lee, Soo Young
    BONE, 2013, 55 (01) : 126 - 131
  • [27] A New Protocol for Predicting Novel GSK-3β ATP Competitive Inhibitors
    Fang, Jiansong
    Huang, Dane
    Zhao, Wenxia
    Ge, Hu
    Luo, Hai-Bin
    Xu, Jun
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (06) : 1431 - 1438
  • [28] A unique type of GSK-3 inhibitor brings new opportunities to the clinic
    Licht-Murava, Avital
    Paz, Rom
    Vaks, Lilach
    Avrahami, Limor
    Plotkin, Batya
    Eisenstein, Miriam
    Eldar-Finkelman, Hagit
    SCIENCE SIGNALING, 2016, 9 (454)
  • [29] Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3
    Sebastian-Perez, Victor
    Martinez de Iturrate, Paula
    Nacher-Vazquez, Montserrat
    Novoa, Luis
    Perez, Concepcion
    Campillo, Nuria E.
    Gil, Carmen
    Rivas, Luis
    BIOMEDICINES, 2022, 10 (05)
  • [30] Famotidine: Is it a potential new candidate for the treatment of schizophrenia by inhibiting GSK-3β?
    Unal, G.
    Dokumaci, A. H.
    Hazar-Yavuz, A. N.
    Aycan, M. B.
    Sahin, C.
    Keles, R.
    Aricioglu, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S526 - S527
12345